Factors Affecting the Price of Exkivity

Exkivity (mobocertinib), a targeted drug for non - small cell lung cancer, has a price influenced by multiple elements. Firstly, high R&D costs play a significant role. 

Factors Affecting the Price of Exkivity

Developing this drug for specific EGFR exon 20 insertion mutations required substantial investment in research, clinical trials, and testing, which is reflected in its price.

Secondly, patent protection gives Takeda, the manufacturer, market exclusivity. Without generic competition during the patent - protected period, they can set a relatively high price.

Moreover, production costs matter. Precise manufacturing processes and strict quality control for its capsules contribute to the overall expense. Market demand also impacts the price. As it targets a specific patient group with a relatively rare mutation, the supply - demand balance affects the price point. Additionally, different regions may have diverse healthcare policies, and insurance coverage can greatly influence the out - of - pocket cost for patients.